IGFBP6 anticorps (Internal Region)
Aperçu rapide pour IGFBP6 anticorps (Internal Region) (ABIN7218254)
Antigène
Voir toutes IGFBP6 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Internal Region
-
Fonction
- IGFBP6 Polyclonal Antibody
-
Specificité
- IGFBP6 Polyclonal Antibody detects endogenous levels of IGFBP6 protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogène
- Synthesized peptide derived from the Internal region of human IGFBP6
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:20000). Not yet tested in other applications.
-
Commentaires
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- IGFBP6 (Insulin-Like Growth Factor Binding Protein 6 (IGFBP6))
-
Autre désignation
- IGFBP6
-
Sujet
- Rabbit Anti-IGFBP6 Polyclonal Antibody,IGFBP6, IBP6, Insulin-like growth factor-binding protein 6, IBP-6, IGF-binding protein 6, IGFBP-6,IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors.,Insulin-like growth factor-binding protein 6
-
Poids moléculaire
- observerd band 25kDa
-
ID gène
- 3489
-
UniProt
- P24592
-
Pathways
- Signalisation WNT, Myometrial Relaxation and Contraction
Antigène
-